BRIDGEWAY CAPITAL MANAGEMENT, LLC

Position in KPTI — Karyopharm Therapeutics Inc.

CIK 1107261 HOUSTON, TX

Position in KPTI

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$702,199

+$301,867 QoQ

Shares Held

71,873

0.0% QoQ

Ownership

0.317%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#40

of 96 holders

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

BRIDGEWAY CAPITAL MANAGEMENT, LLC holds $87,985,615 across 108 Biotechnology names. KPTI ranks #26 (0.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GLUE	Monte Rosa Therapeutics, Inc.	552,566	$13,372,097
2	INVA	Innoviva, Inc.	350,253	$7,954,245
3	PBYI	Puma Biotechnology, Inc.	791,616	$6,420,005
4	RIGL	Rigel Pharmaceuticals Inc	124,184	$4,858,078
5	EXEL	Exelixis, Inc.	66,100	$3,596,501
6	CRMD	CorMedix Inc.	434,132	$3,407,936
7	KROS	Keros Therapeutics, Inc.	265,017	$2,835,681
8	PTCT	Ptc Therapeutics, Inc.	22,000	$1,794,540

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$702,199	71,873	0.0%	Shares	Sole	2026-08-14
2026-03-31	$400,332	71,873	+9.1%	Shares	Sole	2026-05-15
2025-12-31	$484,825	65,873	+88.9%	Shares	Sole	2026-02-17
2025-09-30	$228,069	34,873	-7.8%	Shares	Sole	2025-11-14
2025-06-30	$163,073	37,836	-84.2%	Shares	Sole	2025-08-14
2024-12-31	$161,902	239,500	0.0%	Shares	Sole	2025-02-14
2024-09-30	$198,785	239,500	-9.5%	Shares	Sole	2024-11-14
2024-06-30	$229,586	264,500	+39.6%	Shares	Sole	2024-08-14
2024-03-31	$286,145	189,500	-34.5%	Shares	Sole	2024-05-15
2023-12-31	$250,417	289,500	0.0%	Shares	Sole	2024-02-14
2023-09-30	$387,930	289,500	—	Shares	Sole	2023-11-14
No filing history on record for this holder in this stock.